Amphastar Pharmaceuticals Total Current Liabilities 2012-2024 | AMPH
Amphastar Pharmaceuticals total current liabilities from 2012 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
Amphastar Pharmaceuticals Annual Total Current Liabilities
(Millions of US $) |
| 2023 |
$225 |
| 2022 |
$95 |
| 2021 |
$104 |
| 2020 |
$112 |
| 2019 |
$90 |
| 2018 |
$107 |
| 2017 |
$67 |
| 2016 |
$61 |
| 2015 |
$60 |
| 2014 |
$63 |
| 2013 |
$65 |
| 2012 |
$60 |
| 2011 |
$ |
| 2009 |
$127 |
Amphastar Pharmaceuticals Quarterly Total Current Liabilities
(Millions of US $) |
| 2024-09-30 |
$159 |
| 2024-06-30 |
$137 |
| 2024-03-31 |
$255 |
| 2023-12-31 |
$225 |
| 2023-09-30 |
$258 |
| 2023-06-30 |
$251 |
| 2023-03-31 |
$106 |
| 2022-12-31 |
$95 |
| 2022-09-30 |
$102 |
| 2022-06-30 |
$104 |
| 2022-03-31 |
$114 |
| 2021-12-31 |
$104 |
| 2021-09-30 |
$98 |
| 2021-06-30 |
$125 |
| 2021-03-31 |
$127 |
| 2020-12-31 |
$112 |
| 2020-09-30 |
$97 |
| 2020-06-30 |
$93 |
| 2020-03-31 |
$83 |
| 2019-12-31 |
$90 |
| 2019-09-30 |
$87 |
| 2019-06-30 |
$101 |
| 2019-03-31 |
$112 |
| 2018-12-31 |
$107 |
| 2018-09-30 |
$97 |
| 2018-06-30 |
$88 |
| 2018-03-31 |
$73 |
| 2017-12-31 |
$67 |
| 2017-09-30 |
$57 |
| 2017-06-30 |
$64 |
| 2017-03-31 |
$73 |
| 2016-12-31 |
$61 |
| 2016-09-30 |
$61 |
| 2016-06-30 |
$66 |
| 2016-03-31 |
$65 |
| 2015-12-31 |
$60 |
| 2015-09-30 |
$71 |
| 2015-06-30 |
$69 |
| 2015-03-31 |
$72 |
| 2014-12-31 |
$63 |
| 2014-09-30 |
$63 |
| 2014-06-30 |
$56 |
| 2014-03-31 |
$73 |
| 2013-12-31 |
$65 |
| 2013-09-30 |
|
| 2013-06-30 |
|
| 2013-03-31 |
|
| 2012-12-31 |
$60 |
| 2012-09-30 |
|
| 2012-06-30 |
|
| 2012-03-31 |
|
| 2011-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$2.142B |
$0.644B |
|
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
|
